Valink Therapeutics is a startup based in Switzerland, 1 tracked investor.
Based in Switzerland, Valink Therapeutics is a startup founded in 2023. Brouky records 1 investor associated with the company.
Develops next-generation bispecific and multispecific antibody-drug conjugates (ADCs) for oncology. Uses protein engineering, synthetic biology, high-throughput phenotypic screening and AI-driven discovery to design and optimize cancer therapeutics.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.